HIV/AIDS Urological and Genital Diseases
Conditions
Interventions
HIV PEP PrEP only no serial STI testing and no doxycycline prophylaxis
HIV PEP PrEP serial STI testing and doxycycline prophylaxis
HIV PEP PrEP and Serial STI Testing
Sponsors
University of Washington International Clinical Research Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: • Cis-gender female • Seeking contraception (emergency contraception, oral contraceptive pills, injectables, implants, and condoms) from the retail pharmacy site • Age = 15 and <25 years old • Willingness to receive PrEP screening per national guidelines including HIV testing • Not currently taking PrEP • Willing and eligible to take doxycycline • Planning to reside in the area for the next 12 months • Able and willing to provide informed consent for participation
Exclusion criteria
Exclusion criteria: • Current participation in other ongoing studies. • Medical contraindications to PrEP or doxycycline use (e.g., severe allergy to doxycycline, serious hepatic or renal disease). • Any other condition that, in the investigator’s judgment, would make participation unsafe or interfere with study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HIV PrEP Initiation;HIV PrEP persistence;STI Incidence | — |
Secondary
| Measure | Time frame |
|---|---|
| HIV PEP, PrEP Method Selection;HIV PrEP following PEP;HIV PrEP adherence | — |
Countries
Kenya
Contacts
Public ContactElizabeth Bukusi
Principal Investigator
Outcome results
None listed